| | AMIa | Strokea | Pulmonary Embolisma |
|---|
Total | 5524 | 3434 | 994 |
Males, N (%) | 3774 (68.3%) | 1990 (57.9%) | 510 (51.3%) |
Higher-riskb, N (%) | 5029 (91.0%) | 3126 (91.1%) | 859 (86.3%) |
Lower-riskc, N (%) | 495 (9.0%) | 308 (8.9%) | 136 (13.7%) |
Mean age, years | 67.2 (12.4) | 69.9 (12.5) | 63.4 (16.8) |
- AMI acute myocardial infarction, SD standard deviation
- aOnly first-time AMI or Stroke or Pulmonary embolism cases occurring from May 1st, 2009 through 30th September 2010 or the day of emigration or death (whichever came first) were included
- bHigher risk was defined as being registered in the Norwegian Prescription Database for any of the following drugs: anti-diabetic drugs, anti-obesity drugs, anti-thrombotic drugs, glycosides, anti-arrhythmic drugs, nitrates, beta-blockers, calcium channel blockers, anti-hypertensive drugs, diuretics, peripheral vasodilators or other vasodilators, drugs acting on the renin-angiotensin system, vasoprotective drugs, lipid modifying agents and drugs for obstructive airway diseases from 1st January 2004 until vaccination
- cIn absence of prescriptions to these drugs, we defined individuals as being at lower risk
